Rowland Carmichael Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$610K Hold
8,058
0.19% 120
2020
Q3
$398K Hold
8,058
0.16% 156
2020
Q2
$424K Hold
8,058
0.18% 139
2020
Q1
$284K Buy
8,058
+2,310
+40% +$135K 0.14% 177
2019
Q4
$502K Hold
5,748
0.17% 142
2019
Q3
$488K Hold
5,748
0.17% 144
2019
Q2
$605K Hold
5,748
0.21% 129
2019
Q1
$607K Hold
5,748
0.22% 126
2018
Q4
$481K Hold
5,748
0.21% 121
2018
Q3
$586K Hold
5,748
0.23% 114
2018
Q2
$465K Hold
5,748
0.2% 138
2018
Q1
$424K Hold
5,748
0.23% 131
2017
Q4
$405K Hold
5,748
0.21% 142
2017
Q3
$359K Hold
5,748
0.2% 158
2017
Q2
$330K Hold
5,748
0.19% 159
2017
Q1
$350K Buy
+5,748
New +$325K 0.21% 143

Other funds holding NGVT

Rowland Carmichael Advisors's NGVT Position: Q4 2020 in Review

Rowland Carmichael Advisors held its Ingevity (NGVT) position steady in Q4 2020 at 8,058 shares worth $610K. The position accounts for 0.19% of the portfolio, ranked #120.

Rowland Carmichael Advisors first reported a position in NGVT in Q1 2017 and has held it in 16 quarters since. 285 funds tracked by Wall St. Rank hold NGVT as of Q4 2020.

  • Rowland Carmichael Advisors held 8,058 shares of Ingevity worth $610K as of Q4 2020.
  • Rowland Carmichael Advisors left its Ingevity share count unchanged in Q4 2020.
  • Ingevity made up 0.19% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #120 holding.
  • Rowland Carmichael Advisors first reported a position in Ingevity in Q1 2017 and has held it in 16 quarters since.
  • 285 funds tracked by Wall St. Rank held Ingevity as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.